Article Details

Emyria (ASX:EMD) engages Calvert Labs for preclinical CBD studies - The Market Herald

Retrieved on: 2021-08-27 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Emyria (ASX:EMD) engages Calvert Labs for preclinical CBD studies - The Market Herald. View article details on hiswai:

Excerpt

Emyria (EMD) pens a master services agreement (MSA) with US-based preclinical contract research organisation, Calvert Labs; Calvert will design and deliver ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up